ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation
ImmunityBio presented new patient survey data at ISPOR 2026 showing that a majority of UK adults with high-risk NMIBC favor bladder preservation over radical cystectomy. The study, conducted with Fight Bladder Cancer, surveyed 86 patients and found that treatment preferences are highly individualized, driven by quality-of-life concerns and past experiences.
Key figures
- Survey participants
- 86
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.